Haleon HLN
NYSE HLN
$9.90 +0.03 (+0.25%)
At close: Aug 20, 2026 · 2:57 PM UTC

Haleon (HLN) Other Non-Current Liabilities (2021 - 2026)

Haleon's (HLN) quarterly Other Non-Current Liabilities came in at -$52.3 million in Q2 2026, down 30.18% on a QoQ basis from -$40.2 million in Q4 2025.

Haleon (HLN) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends

Haleon (HLN) has 6 years of Other Non-Current Liabilities data on file, last reported at -$52.3 million in Q2 2026.

  • Quarterly Other Non-Current Liabilities changed N/A year-over-year to -$52.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$52.3 million (changed N/A YoY) and the FY2025 annual result came in at -$39.9 million, down 154.77% from the prior year.
  • Other Non-Current Liabilities slipped to -$52.3 million in Q2 2026, from -$40.2 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $73.2 million in Q4 2024 to a low of -$83.1 million in Q2 2022.
  • A 5-year average of -$8.5 million and a median of -$30.8 million in 2023 frame the typical range for Other Non-Current Liabilities.
  • Annual changes were most pronounced in 2023 — Other Non-Current Liabilities jumped 115.7% — and 2025, when it tumbled 154.94%.
  • Tracing HLN's Other Non-Current Liabilities over 5 years: stood at $30.5 million in 2022, then surged by 115.7% to $65.8 million in 2023, then rose by 11.22% to $73.2 million in 2024, then plunged by 154.94% to -$40.2 million in 2025, then plunged by 30.18% to -$52.3 million in 2026.
  • The last three Other Non-Current Liabilities figures came in at -$52.3 million (Q2 2026), -$40.2 million (Q4 2025), and $73.2 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.94 Bn 42.97 Bn -
2 Teva Pharmaceutical Industries 43.08 Bn 39.43 Bn 2.15 Bn
3 Zoetis 31.54 Bn 29.87 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.60 Bn 22.80 Bn 5.10 Bn
5 United Therapeutics 22.12 Bn 19.46 Bn 683.80 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn
7 Neurocrine Biosciences 15.50 Bn 15.11 Bn 935.80 Mn
8 Elanco Animal Health 11.69 Bn 11.16 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.13 Bn 9.96 Bn -
10 Alkermes 8.09 Bn 7.43 Bn 397.90 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -52.33 Mn
Dec 31, 2025 -40.19 Mn
Dec 31, 2024 73.16 Mn
Jun 30, 2024 -34.08 Mn
Dec 31, 2023 65.78 Mn
Jun 30, 2023 -27.53 Mn
Dec 31, 2022 30.50 Mn
Jun 30, 2022 -83.11 Mn
Dec 31, 2021 36.40 Mn